All lobbying filings

CGCN Group, LLC

CGCN Group, LLC filed a Q1 report for Partner Therapeutics, Inc. on April 20, 2026, reporting $80,000 in lobbying income.

Lobbying for Partner Therapeutics, Inc. · Biopharmaceutical company

As filed: CGCN GROUP, LLC for PARTNER THERAPEUTICS, INC.

All filings by CGCN Group, LLC · Everything Partner Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Defense

Issues related to medical countermeasures for Acute Radiation Syndrome (ARS).

Health Issues

Issues pertaining to the development of public health emergency medical countermeasures. Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.